- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05829915
mHealth Technology in People With Parkinson's Disease (HomTrainPark)
Feasibility and Efficacy of a Home Exercise Program Using mHealth Technology in People With Parkinson's Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Parkinson's disease (PD) is a neurological disease whose motor symptoms drastically affect the quality of life of those who suffer from it. There is currently high scientific evidence of the positive effect of physical exercise on the motor function of people with PD. This effect seems to be more relevant when this physical exercise is implemented with external sensory signals (eg visual, auditory). However, the health and socioeconomic context of the patient conditions their access to treatments and physical exercise programs, associationism being common as a low-cost strategy to cover the different therapies. The development of telemedicine, electronic devices and mobile health applications could be an interesting option for those patients who find themselves in the situations mentioned above. However, there are several limitations regarding the use of mobile health apps, such as that less than
1% of them are grounded in research evidence and the digital barrier. Therefore, the main objective of the study is to explore the feasibility and effectiveness of this type of mHalth technology in the treatment of motor symptoms in people with Parkinson's disease.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Miguel Fernandez del Olmo
- Phone Number: 0034600077866
- Email: miguel.delolmo@urjc.es
Study Contact Backup
- Name: Alfonso Jimemez Gutierrez
- Phone Number: 0034914888401
- Email: alfonso.jimenez@urjc.es
Study Locations
-
-
Madrid
-
Fuenlabrada, Madrid, Spain, 28942
- Recruiting
- Universidad Rey Juan Carlos
-
Contact:
- Miguel Angel Fernández del Olmo, PhD
- Phone Number: 600077866
- Email: miguel.delolmo@urjc.es
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Absence of treatment with psychotropic drugs or stable dose of the same (without drug or dose modifications in the last four weeks).
In the case of subjects who are part of the intervention group, the following will also be inclusion criteria:
- Caregiver or family member who presents the appropriate skills for collaboration in the implementation of the exercises and in the management of the mobile application.
- Availability of the necessary time for the initial training in the handling of the devices, the development of the sessions and the communication with the researchers.
Exclusion Criteria:
- Insufficient physical condition for participation.
- Sensory deficits that make participation difficult.
- Unstable clinical situation.
- Unstable mental disorder or not adequately controlled with medication (depression, agitation, etc.).
- Presence of associated pathology that involves treatment with drugs that alter cognitive abilities or interfere with the user's participation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Group
Subjects in the intervention group will perform 24 sessions of multisensory training using ROXPro© system (A-Champs)
|
The intervention consisted in 24 sessions (3/week) of a cognitive-multisensory-physical exercise program carried out in the patient's own home.
The exercise program was designed by qualified personal trainers and psychologists, and implemented with the ROXPro© system (A-Champs) (https://a-champs.com;
accessed on 8 January 2022).
This system consists of small devices that provide visual, auditory and vibration stimuli with which the patient interacts.
Through its mobile application, it allows the development of numerous sensory-cognitive-motor exercises adapted to the characteristics of the patients.
|
Active Comparator: Control Group
Subjects in the Control Group will not perform 24 sessions of multisensory training and they will keep doing the current therapy
|
The control group did not received the physical exercise program
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Speed of gait at preferred pace
Time Frame: baseline
|
Speed (m/s)
|
baseline
|
Speed of gait at preferred pace
Time Frame: at week 8
|
Speed (m/s)
|
at week 8
|
Cadence of gait at preferred pace
Time Frame: Baseline
|
cadence (steps/min)
|
Baseline
|
Cadence of gait at preferred pace
Time Frame: At week 8
|
cadence (steps/min)
|
At week 8
|
Step Length of gait at preferred pace
Time Frame: Baseline
|
Step Length (m)
|
Baseline
|
Step Length of gait at preferred pace
Time Frame: At week 8
|
Step Length (m)
|
At week 8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time up & go test
Time Frame: Baseline
|
Time (seconds)
|
Baseline
|
Time up & go test
Time Frame: At week 8
|
Time (seconds)
|
At week 8
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0801202000720
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on ROXPro© system (A-Champs)
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Samuel Lunenfeld Research Institute, Mount Sinai...CompletedQuality of RecoveryCanada
-
University of Vic - Central University of CataloniaCompletedFatigue | Physical Stress | SoccerSpain
-
Cairo UniversityRecruiting
-
University Hospital, MontpellierADENERecruiting
-
University of EdinburghCancer Research UKCompleted
-
Chelsea and Westminster NHS Foundation TrustCompleted
-
University Health Network, TorontoOntario Ministry of Health and Long Term CareCompletedStroke | Deglutition Disorders | DysphagiaCanada, United States
-
Université Libre de BruxellesCompleted
-
Technical University of MunichCompleted